Fact CheckerSign in

NCT06908057Active, not recruiting

Accessing Care, Clinical Trials and Screening for Underserved Children and Adults With Type 1 Diabetes (ACCESS-T1D)

Access to Clinical Care, Education and Screening for Underserved Children and Adults With Type 1 Diabetes (ACCESS-T1D)

Source: ClinicalTrials.gov · Last updated 12 Aug 2026

Brief summary (registry, in English)

The purpose of this study is to identify people with T1D or celiac disease (CD) early in the course of their disease and to improve the methods of screening for these diseases.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
115 (actual)
First submitted
12 Mar 2025
Start date
11 Mar 2024
Primary completion date
Dec 2026
Lead sponsor
AdventHealth Translational Research Institute
NCT number
NCT06908057

What you commit to

  • Study type: Observational
  • Participants enrolled: 115
  • From 11 Mar 2024 to the primary completion date, Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of organ transplant
  • Presence of any condition that, in the opinion of the Investigator, compromises participant safety or data integrity or the participant's ability to complete study visit/s.

Other

  • People with a diagnosis of type stage 3T1D or T1D clinical definition per ADA Standards of Care
  • Be deemed unable or unlikely to comply with the protocol.

Who the study is looking for

  • Able to provide informed consent (adults 18 and above) and assent if seven or above. Legally authorized representative (LAR) is able to provide consent in case of minors or in case of adults unable to consent.
  • Children \> 2 years and adults at elevated risk of developing (or having misdiagnosed) clinically evident Stage 3 T1D because they have at least one of the following:
    • have one or more first- or second-degree family members (siblings, parents, cousins, aunts/uncles, grandparents) diagnosed with type 1 diabetes or ii. have other autoimmune diseases such as but not limited to celiac disease, Multiple sclerosis, rheumatoid arthritis or, thyroid disease or iii. Those diagnosed with other forms of diabetes which are suspected of being T1D because of a BMI ≤28 or progression to insulin dependence within 3 years from diagnosis.
  • Resides in the following Counties: Orange, Seminole, Osceola, Lake, Volusia, Brevard, Polk, Hillsborough.

Age in the registry: 2 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
AdventHealth Translational Research Institute
Coordinator of this site? Confirm its status
OrlandoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.